biotech · Melanoma · Previously untreated, unresectable, or metastatic melanoma · IOBTQ
IO Biotech
IO Biotech patent portfolio — 21 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Ole Maaloesvej 3, Copenhagen, Denmark 2200, DK
- Founded
- 2015
- Employees
- 50
- Programs
- 16
- Drugs
- 8
- Patents
- 21
IO Biotech patents
21 pharmaceutical patents indexed for IO Biotech. 0 expire within 24 months.
IO Biotech has 21 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12234288
Immunogenic arginase 2 polypeptides
granted -
US 12233103
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 12215135
PDL2 compounds
granted -
US 12194081
ARGINASE1 polypeptides
granted -
US 12187782
PDL1 peptides for use in cancer vaccines
granted -
US 12077785
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
granted -
US 11981944
Immunogenic arginase peptides
granted -
US 11878053
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
granted -
US 11648302
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 11564891
Chloroquine gel and preparation method and application thereof
granted -
US 11447537
PDL2 compounds
granted -
US 11324813
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 11298413
Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof
granted -
US 11147773
Chloroquine gel and preparation method and application thereof
granted -
US 10858642
Immunogenic arginase peptides
granted -
US 10258678
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 9765378
Preparation method of new recombinant antibacterial polypeptide medicine
granted -
US 9433666
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 9289468
Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof
granted -
US 8187606
HPV antigen fusion protein vaccine compositions and uses thereof
granted -
US 7666989
Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
granted
Frequently asked questions
How many patents does IO Biotech have?
21 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do IO Biotech patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.